Martin Sanders
Chief Executive Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Martin Sanders is the Chief Executive Officer at Io Therapeutics in the United States. His recent research focuses on innovative cancer therapies, particularly regarding the effects of IRX4204 on HER2-positive breast cancer. His work contributes to the development of synergistic treatments aimed at improving patient outcomes in breast cancer care.
Articles (1)
Year:
2024
Collaborators (1)
Powel Brown
Professor and Chairman
The University of Texas MD Anderson Cancer Center
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.